EUVIMEDEUVIMED entdecken
VergleichsstudieRandomisierte kontrollierte StudieOpen Access

Oral live attenuated polio vaccines induce enhanced T-cell responses with broad antigen recognition compared to inactivated polio vaccines

Julia Snyder, Marni Slavik, Patrick Harvey, Roxana Del Rio-Guerra, Bernardo A Mainou, Alessandro Sette, Beth D Kirkpatrick, Alba Grifoni, Jessica W Crothers

Clinical Immunology · 2026-01 · 282 · 110607

DOI: 10.1016/j.clim.2025.110607 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Clinical Immunology, 2026-01. Verfasst von Julia Snyder und 8 weiteren Autor:innen. Beteiligte Einrichtung: University of Vermont Department of Pathology and Laboratory Medicine, Larner College of Medicine, Burlington, VT 05405, USA. Hauptthemen laut MEDLINE: Poliovirus Vaccine, Oral, Poliovirus Vaccine, Inactivated, CD8-Positive T-Lymphocytes, CD4-Positive T-Lymphocytes. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAID NIH HHS, NIGMS NIH HHS, University of Vermont.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Little is known about the immunologic mechanisms responsible for observed differences in mucosal immunity following vaccination with oral live attenuated polio vaccines (OPVs) compared to inactivated polio vaccines (IPVs). Here, we used a flow cytometric activation-induced marker (AIM)-based approach to investigate vaccine-related differences in T cell response using peripheral blood samples from healthy adults enrolled in two polio vaccine trials. Our findings indicate that vaccination with OPVs (1) enhances CD4+ T cell responses, and (2) expands CD4+ and CD8+ antigen recognition of non-structural proteins. Fecal shedding of OPVs was associated with enhanced T cell responses, and primary CD8+ T cell responses appear to correlate with early control of fecal viral shedding. Our results indicate that OPVs induce broad cellular immunity to polioviruses, which may help explain their enhanced ability to stimulate effective pathogen-specific mucosal immunity.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Poliovirus Vaccine, OralPoliovirus Vaccine, InactivatedCD8-Positive T-LymphocytesCD4-Positive T-LymphocytesPoliomyelitisHumansVaccines, AttenuatedAdultVirus SheddingPoliovirusFemaleMaleImmunity, MucosalYoung AdultFecesAntigens, ViralAdministration, Oral

Stichwörter der Autor:innen

Antigen-specific T cellsCellular vaccine immunityIPVMucosal immunityOPVPolioPoliomyelitisViral shedding

Substanzen

Vaccines, AttenuatedPoliovirus Vaccine, OralPoliovirus Vaccine, InactivatedAntigens, Viral

Autor:innen und Institutionen

  • University of Vermont Department of Pathology and Laboratory Medicine, Larner College of Medicine, Burlington, VT 05405, USA.
  • University of Vermont Vaccine Testing Center, Department of Microbiology and Molecular Genetics, Larner College of Medicine, University of Vermont, Burlington, VT 05405, USA.
  • Flow Cytometry and Small Particles Detection Facility (RRID:SCR_022147), Department of Surgery, Larner College of Medicine, University of Vermont, 149 Beaumont Ave, Burlington, VT 05401, USA.
  • Polio and Picornavirus Branch, Centers for Disease Control and Prevention, Atlanta, GA 30329, USA.
  • Center for Vaccine Innovation, La Jolla Institute for Immunology (LJI), La Jolla, CA 92037, USA; Department of Pathology, University of California, San Diego, La Jolla, CA 92093, USA.
  • University of Vermont Vaccine Testing Center, Department of Microbiology and Molecular Genetics, Larner College of Medicine, University of Vermont, Burlington, VT 05405, USA; Department of Medicine, Larner College of Me…

Förderung

  • NIAID NIH HHS
  • NIGMS NIH HHS
  • University of Vermont
  • National Institute of Allergy and Infectious Diseases
  • National Institutes of Health
  • National Institute of General Medical Sciences
  • U.S. Public Health Service
  • U.S. Department of Health and Human Services

Zitieren

APA

Snyder, J., Slavik, M., Harvey, P., Del Rio-Guerra, R., Mainou, B. A., Sette, A., Kirkpatrick, B. D., Grifoni, A., & Crothers, J. W. (2026). Oral live attenuated polio vaccines induce enhanced T-cell responses with broad antigen recognition compared to inactivated polio vaccines. Clinical Immunology, 282, 110607. https://doi.org/10.1016/j.clim.2025.110607

Vancouver

Snyder J, Slavik M, Harvey P, Del Rio-Guerra R, Mainou BA, Sette A, et al. Oral live attenuated polio vaccines induce enhanced T-cell responses with broad antigen recognition compared to inactivated polio vaccines. Clinical Immunology. 2026;282:110607. doi:10.1016/j.clim.2025.110607

BibTeX
@article{Snyder2026,
  author = {Snyder, Julia and Slavik, Marni and Harvey, Patrick and Del Rio-Guerra, Roxana and Mainou, Bernardo A and Sette, Alessandro and Kirkpatrick, Beth D and Grifoni, Alba and Crothers, Jessica W},
  title = {Oral live attenuated polio vaccines induce enhanced T-cell responses with broad antigen recognition compared to inactivated polio vaccines},
  journal = {Clinical Immunology},
  year = {2026},
  volume = {282},
  pages = {110607},
  doi = {10.1016/j.clim.2025.110607}
}
Kostenlos starten →